Massimo Barberis

7.4k total citations
204 papers, 4.2k citations indexed

About

Massimo Barberis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Massimo Barberis has authored 204 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 74 papers in Pulmonary and Respiratory Medicine and 60 papers in Cancer Research. Recurrent topics in Massimo Barberis's work include Lung Cancer Treatments and Mutations (51 papers), Cancer Genomics and Diagnostics (48 papers) and Lung Cancer Research Studies (25 papers). Massimo Barberis is often cited by papers focused on Lung Cancer Treatments and Mutations (51 papers), Cancer Genomics and Diagnostics (48 papers) and Lung Cancer Research Studies (25 papers). Massimo Barberis collaborates with scholars based in Italy, United States and Netherlands. Massimo Barberis's co-authors include Caterina Fumagalli, Lorenzo Spaggiari, Filippo de Marinis, Elena Guerini‐Rocco, Gianluca Spitaleri, Giuseppe Viale, Maria Cannone, Chiara Catania, Davide Vacirca and Francesca Toffalorio and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Massimo Barberis

194 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Barberis Italy	38	1.9k	1.5k	884	849	727	204	4.2k
Stephen L. Graziano United States	39	2.8k 1.4×	2.9k 2.0×	695 0.8×	1.3k 1.5×	559 0.8×	117	5.2k
Jussuf T. Kaifi United States	35	2.4k 1.2×	1.1k 0.8×	635 0.7×	987 1.2×	480 0.7×	164	4.2k
Kiyotaka Yoh Japan	35	3.0k 1.6×	2.6k 1.8×	740 0.8×	1.4k 1.6×	562 0.8×	271	4.6k
Seiji Niho Japan	37	3.2k 1.7×	3.0k 2.1×	547 0.6×	1.1k 1.3×	894 1.2×	213	5.1k
Thomas Knösel Germany	38	1.6k 0.8×	1.2k 0.8×	618 0.7×	1.5k 1.8×	398 0.5×	176	4.3k
Niels Willi Switzerland	24	1.7k 0.9×	1.7k 1.2×	623 0.7×	1.5k 1.8×	208 0.3×	45	4.7k
Jianrong Wu United States	38	1.4k 0.7×	1.6k 1.1×	571 0.6×	1.5k 1.7×	199 0.3×	158	4.5k
Luca Di Tommaso Italy	38	1.6k 0.8×	653 0.4×	1.0k 1.2×	1.2k 1.5×	1.2k 1.6×	162	4.7k
Marie Christine Aubry United States	29	1.3k 0.7×	1.4k 1.0×	368 0.4×	598 0.7×	375 0.5×	102	2.9k
Tetsuro Kodama Japan	39	1.9k 1.0×	2.1k 1.5×	338 0.4×	1.0k 1.2×	830 1.1×	156	4.4k

Countries citing papers authored by Massimo Barberis

Since Specialization

Citations

This map shows the geographic impact of Massimo Barberis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Barberis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Barberis more than expected).

Fields of papers citing papers by Massimo Barberis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Barberis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Barberis. The network helps show where Massimo Barberis may publish in the future.

Co-authorship network of co-authors of Massimo Barberis

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Barberis. A scholar is included among the top collaborators of Massimo Barberis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Barberis. Massimo Barberis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barberis, Massimo. (2025). Shortage of Pathologists: a candid narrative. Pathologica. 117(4). 452–454.

Maffini, Fausto, Francesco Chu, Marta Tagliabue, et al.. (2024). A Transcriptomic Analysis of Laryngeal Dysplasia. International Journal of Molecular Sciences. 25(17). 9685–9685.

Belli, Carmen, Luca Boscolo Bielo, Matteo Repetto, et al.. (2024). Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers. The Oncologist. 29(8). 707–715. 2 indexed citations

Bielo, Luca Boscolo, Matteo Repetto, Edoardo Crimini, et al.. (2024). Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The Oncologist. 29(7). 560–565. 2 indexed citations

Vitis, Luigi Antonio De, Giuseppe Caruso, Caterina Fumagalli, et al.. (2023). Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review. International Journal of Gynecological Cancer. 34(2). 229–238. 23 indexed citations

Ranghiero, Alberto, Chiara Frascarelli, Giulia Cursano, et al.. (2023). Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing. Cytopathology. 34(6). 519–529. 10 indexed citations

Chu, Francesco, Fausto Maffini, Davide Vacirca, et al.. (2023). The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal Dysplasia. Cancers. 15(4). 1117–1117. 2 indexed citations

Corso, Giovanni, Monica Marabelli, Mariarosaria Calvello, et al.. (2023). Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene. European Journal of Human Genetics. 31(11). 1275–1282. 8 indexed citations

Vitis, Luigi Antonio De, Caterina Fumagalli, Paola Rafaniello Raviele, et al.. (2022). 2022-RA-1289-ESGO Understanding clinical and pathological heterogeneity of endometrial cancer with no specific molecular profile (NSMP). International Journal of Gynecological Cancer. 32. A141–A141. 1 indexed citations

10.

Vitis, Luigi Antonio De, Caterina Fumagalli, Paola Rafaniello Raviele, et al.. (2022). 2022-RA-659-ESGO The role of molecular classification in endometrial cancers with lymph nodes metastasis. International Journal of Gynecological Cancer. 32. A103–A104. 1 indexed citations

11.

Betella, Ilaria, Caterina Fumagalli, Paola Rafaniello Raviele, et al.. (2022). A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer. International Journal of Gynecological Cancer. 32(8). 993–1000. 27 indexed citations

12.

Girolami, Ilaria, Liron Pantanowitz, Massimo Barberis, et al.. (2021). Challenges facing pathologists evaluating PD‐L1 in head & neck squamous cell carcinoma. Journal of Oral Pathology and Medicine. 50(9). 864–873. 35 indexed citations

13.

Betella, Ilaria, Alessandra Rappa, Davide Vacirca, et al.. (2021). Microsatellite instability evaluation: which test to use for endometrial cancer?. Journal of Clinical Pathology. 76(1). 29–33. 8 indexed citations

14.

Croci, Giorgio Alberto, Valentina Vaira, Daria Trabattoni, et al.. (2021). Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients. Cells. 10(3). 611–611. 12 indexed citations

15.

Fumagalli, Caterina, Elena Guerini‐Rocco, Fiamma Buttitta, et al.. (2020). Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network. Journal of Clinical Pathology. 74(10). 668–672. 3 indexed citations

16.

Kroeze, Leonie I., Richarda M. de Voer, Eveline J. Kamping, et al.. (2020). Evaluation of a Hybrid Capture–Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes. Journal of Molecular Diagnostics. 22(6). 757–769. 43 indexed citations

17.

Lazzeroni, Matteo, Andrea DeCensi, Aliana Guerrieri‐Gonzaga, et al.. (2020). Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast. Modern Pathology. 33(6). 1065–1077. 5 indexed citations

18.

Dama, Elisa, Fabio Dezi, Rose Mary Carletti, et al.. (2016). An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers. Clinical Cancer Research. 23(1). 62–72. 26 indexed citations

19.

Wistuba, Ignacio I., Carmen Behrens, Francesca Lombardi, et al.. (2013). Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma. Clinical Cancer Research. 19(22). 6261–6271. 84 indexed citations

20.

Marchetti, Antonio, Andrea Ardizzoni, Mauro Papotti, et al.. (2013). Recommendations for the Analysis of ALK Gene Rearrangements in Non–Small-Cell Lung Cancer: A Consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology. Journal of Thoracic Oncology. 8(3). 352–358. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact